Advicenne | ALDVI Logo | Annual Report & Investor Relations Data

Advicenne | ALDVI Annual Report & Investor Relations Data

ISIN

FR0013296746

Ticker

ALDVI

Sector

Health Care

Industry

Biotechnology

Country

France

Year Founded

Advicenne (ALDVI)
Company Overview & Profile

Company Description

For more than 10 years, Advicenne has been dedicated to developing innovative, effective and safe treatments for people living with rare renal diseases who have very limited therapeutic options. Thanks to our expertise in reformulation and drug delivery, we are uniquely positioned to develop and make available innovative treatments for both children and adults with rare renal diseases.

At Advicenne we are dedicated to improving patients’ daily health and life. Our employees in France and the United States are committed to tackle the challenge of high unmet medical need to improve quality of life for patients and their caregivers.

Sibnayal® (combination of Potassium citrate and Potassium bicarbonate) was in 2021 approved by the European Medicine Agency and MHRA.

Served Area

Worldwide

Headquarters

3ème étage 262 Rue du Faubourg Saint-Honoré
75008, Paris
France

Advicenne (ALDVI)
Filings & Annual Reports

Filters

View all types
Type Document Details Language Filing Date File Number

Get API Access

Access comprehensive European stock market filings data through a single, powerful API.

1,5M+

filings covered

18

European countries

30min

max latency

1 API

for all filings

Advicenne (ALDVI)
Insider Trading Activity

Date Trading entity / Person Association Trade type Volume
04.10.2023 None Other Other EUR 3,499,999.62
04.10.2023 None Other Buy EUR 99,998.13
02.10.2023 None Other Other EUR 999,998.17
21.09.2023 None Other Sell EUR 22.34
15.09.2023 None Other Sell EUR 13.45

Advicenne (ALDVI)
Leadership: Management & Supervisory Board

No Leadership Information Available

We currently don't have information about the management or supervisory board for this company. This information will be updated as soon as it becomes available.

Advicenne (ALDVI)
Stock & Investor Information

ISIN

FR0013296746

LEI

969500YT5VMEYAYODW34

Stock Exchange Listings

Euronext Paris

Primary Stock Exchange Listing

View Advicenne on main stock exchange

Industry Classification

Advicenne (ALDVI)
Related Companies & Peer Group

4SC AG Logo

4SC AG

VSC

Sector

Health Care

Country

Germany

ISIN

DE000A3E5C40

Founded

1997

4SC focuses on the development of novel small molecule drugs that target key mechanisms of cancer development, such as histone …

ABIONYX Pharma Logo

ABIONYX Pharma

ABNX

Sector

Health Care

Country

France

ISIN

FR0012616852

Founded

ABIONYX Pharma is a new-generation biotech company that aims to contribute to health through innovative therapies in indications where there …

Abliva Logo

Abliva

ABLI

Sector

Health Care

Country

Sweden

ISIN

SE0002575340

Founded

2000

Abliva develops medicines for the treatment of primary mitochondrial diseases. These congenital, rare and often very severe diseases occur when …

AB Science Logo

AB Science

AB

Sector

Health Care

Country

France

ISIN

FR0010557264

Founded

2001

AB Science is a late-clinical-stage French company founded in 2001 by a team of scientists with the goal of developing …

Acticor Biotech Logo

Acticor Biotech

ALACT

Sector

Health Care

Country

France

ISIN

FR0014005OJ5

Founded

Acticor Biotech is a spin-off from Inserm (French National Institute of Health and Medical Research) dedicated to the development of …

Active Biotech Logo

Active Biotech

ACTI

Sector

Health Care

Country

Sweden

ISIN

SE0001137985

Founded

1998

Active Biotech develops pharmaceutical products within medical areas where the immune system is of significant importance, including cancer and inflammatory …